21/02/2026
Here are the key patient benefits of MCT (Meta Cell Technology) compared to standard exosome solutions:
* Autologous Safety: Because the treatment uses your own biological material, there is a significantly lower risk of immune rejection or adverse reactions compared to donor-derived (allogeneic) exosome products.
* Increased Potency: The photothermal activation triggers a higher concentration of growth factors and exosomes—up to three times more than standard treatments—enhancing the healing potential.
* Improved Comfort: The specialized processing reduces the viscosity of the injectable, which often leads to a more comfortable and less painful injection experience.
* Cellular Vitality: The treatment “primes” the mitochondria of the cells, giving them more energy (ATP) to survive and function effectively once they are injected into the target area.
* Immediate Processing: The solution is prepared and activated on-site during the appointment, ensuring the biological material is fresh and hasn’t lost potency through freezing or long-term storage.
* Lower Inflammation: The device helps filter out pro-inflammatory markers before the injection, creating a more favorable environment for tissue repair and pain reduction.
